The Library
Why Insulin Sensitivity May Be One of the Most Important Biomarkers of Healthy Ageing
Insulin sensitivity describes how clearly tissues hear one of the body's central energy signals. Research suggests it may be as informative about healthy ageing as it is about diabetes risk.
01 September 2026

The meal that used to leave you clear
There is a particular kind of afternoon that many high performers begin to recognise in their thirties and forties.
The morning was sharp.
The lunch was ordinary.
Then, somewhere between the second meeting and the third, the mind thickens.
Most people describe this as ageing.
Or stress.
Or a heavy lunch.
It is often more useful to think of it as a change in how the body handles insulin.
Insulin is not a diabetes hormone.
It is one of the body's principal instructions for storing, releasing and using energy.
When that instruction is heard clearly, glucose moves into muscle, the liver behaves itself, and energy remains relatively stable.
When the instruction is muffled, the same meal produces a different afternoon.
What insulin sensitivity actually measures
Insulin sensitivity describes how readily tissues respond to insulin's signal.
Muscle is the largest of those tissues.
It is, in practical terms, a glucose sink.
The more effectively muscle responds, the less insulin the pancreas needs to issue in order to keep blood glucose within a useful range.
The inverse is also true.
When muscle, liver or adipose tissue become less responsive, the body compensates by producing more insulin.
For a time, glucose numbers can still look acceptable.
The compensation is the story.
Fasting glucose, on its own, is a late measure.
By the time it is clearly elevated, the signalling system has often been under strain for years.
Researchers have associated reduced insulin sensitivity with cardiovascular risk, fatty liver, changes in body composition and, in some studies, aspects of cognitive ageing.
The evidence is not that insulin resistance causes ageing in a simple sense.
It is that declining insulin sensitivity sits close to several of the processes that make ageing feel like decline.
Why the signal fades
The decline is rarely a single failure.
Sleep restriction can blunt insulin action within days.
Visceral fat is metabolically active in ways that subcutaneous fat is not, and is associated with poorer insulin signalling.
Physical inactivity reduces the muscle's appetite for glucose.
Chronic psychological stress keeps cortisol in the conversation, which can raise glucose independently of food.
Ageing itself changes body composition: less muscle, more central fat, a quieter mitochondrial engine.
None of these is exotic.
Together they produce a system that needs more insulin to do the same work.
Most people notice the downstream effects first.
Energy that arrives in spikes.
Hunger that returns too soon.
A waist that changes faster than the scale.
Difficulty losing fat despite eating reasonably.
These are not character flaws.
They are signals.
A biomarker of ageing, not a diabetes test
Clinical medicine has historically treated insulin as a diabetes concern.
That framing is too narrow.
Diabetes is one possible destination of a long decline in metabolic signalling.
Healthy ageing is interested in the slope, not only the cliff.
Researchers increasingly treat insulin sensitivity as a marker of metabolic age: a way of asking how efficiently the organism still manages energy.
It is not the only marker that matters.
It is one of the more informative.
A person can have a respectable body weight and still be insulin resistant.
A person can carry more body fat and still handle glucose well, particularly if they also carry more muscle.
This is why the bathroom scale is such a poor instrument for this conversation.
What can actually be measured
Insulin sensitivity is not guessed from a single number.
Clinicians may look at a combination of signals, depending on context:
- Fasting insulin, sometimes interpreted alongside fasting glucose
- Estimates such as HOMA-IR, which combine those values
- Triglycerides and HDL, which often move with metabolic health
- Waist circumference and, where available, visceral fat imaging
- Glucose responses over time, including oral glucose tests or continuous monitoring
- Body composition, particularly lean mass
- Clinical history: sleep, training, alcohol, medications and family risk
None of these, alone, is a verdict.
Together they begin to describe a system.
The practical question is not simply whether diabetes is present.
It is how much work the signalling system is doing to keep the picture looking well.
The Ninth Perspective
At The Ninth, we believe insulin sensitivity is less a specialist concern and more a map of how the body is ageing in real time.
The first step is rarely a new intervention.
It is a clearer picture of how your own system handles energy, recovery and load.
Understanding that biology is the beginning of a more intelligent conversation.
Read more from the library

09 Sept 2026
BPC-157: What the Latest Research Actually Tells Us
BPC-157 is widely discussed as a repair peptide. The published evidence is still largely preclinical. This piece looks at what the research actually shows, and what it does not.

07 Sept 2026
What Continuous Glucose Monitoring Can Tell You If You Don't Have Diabetes
Continuous glucose monitoring is no longer only a diabetes tool. For people without diabetes, it can reveal how sleep, meals, stress and training shape glucose variability through the day.

02 Sept 2026
Beyond GLP-1: The Rise of Multi-Receptor Peptide Therapies
Clinical research is moving from single-receptor incretin medicines toward therapies that engage more than one metabolic pathway. The story is the signalling system, not a single molecule.